Piechaczyk, Marc
143  results:
Search for persons X
?
2

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with..:

Gabellier, Ludovic ; de Toledo, Marion ; Chakraborty, Mehuli...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2023.282704.  , 2023
 
?
4

DeSUMOylation of chromatin-bound proteins limits the rapid ..:

Boulanger, Mathias ; Aqrouq, Mays ; Tempé, Denis...
info:eu-repo/semantics/altIdentifier/doi/10.1093/nar/gkad581.  , 2023
 
?
5

Multiple Fra-1-bound enhancers showing different molecular ..:

Bejjani, Fabienne ; Evanno, Emilie ; Mahfoud, Samantha...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13578-023-01077-5.  , 2023
 
?
6

DeSUMOylation of chromatin-bound proteins limits the rapid ..:

Boulanger, Mathias ; Aqrouq, Mays ; Tempé, Denis...
info:eu-repo/semantics/altIdentifier/doi/10.1093/nar/gkad581.  , 2023
 
?
7

Multiple Fra-1-bound enhancers showing different molecular ..:

Bejjani, Fabienne ; Evanno, Emilie ; Mahfoud, Samantha...
info:eu-repo/semantics/altIdentifier/doi/10.1186/s13578-023-01077-5.  , 2023
 
?
8

SUMOylation inhibitor TAK-981 (subasumstat) synergizes with..:

Gabellier, Ludovic ; de Toledo, Marion ; Chakraborty, Mehuli...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2023.282704.  , 2023
 
?
9

SUMOylation controls the rapid transcriptional reprogrammin..:

Boulanger, Mathias ; Kifagi, Chamseddine ; Ristic, Marko...
info:eu-repo/semantics/altIdentifier/doi/10.1101/2022.04.19.488613.  , 2022
 
?
10

The NADPH oxidase NOX2 is a marker of adverse prognosis inv..:

Paolillo, Rosa ; Boulanger, Mathias ; Gâtel, Pierre...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.279889.  , 2022
 
?
11

The NADPH oxidase NOX2 is a marker of adverse prognosis inv..:

Paolillo, Rosa ; Boulanger, Mathias ; Gâtel, Pierre...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.279889.  , 2022
 
?
13

The NADPH oxidase NOX2 is a marker of adverse prognosis inv..:

Paolillo, Rosa ; Boulanger, Mathias ; Gâtel, Pierre...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.279889.  , 2022
 
1-15